ARCOS Transaction Reporting

ICR 201101-1117-001

OMB: 1117-0003

Federal Form Document

Forms and Documents
Document
Name
Status
Form
Modified
Supplementary Document
2008-04-22
Supporting Statement A
2011-07-27
IC Document Collections
IC ID
Document
Title
Status
12279 Modified
ICR Details
1117-0003 201101-1117-001
Historical Active 200712-1117-002
DOJ/DEA
ARCOS Transaction Reporting
Extension without change of a currently approved collection   No
Regular
Approved without change 07/30/2011
Retrieve Notice of Action (NOA) 06/07/2011
  Inventory as of this Action Requested Previously Approved
07/31/2014 36 Months From Approved 07/31/2011
6,856 0 7,768
6,856 0 7,768
218 0 9,077

21 USC 827 requires that all manufacturers and distributors report acquisitional/distribution transactions of controlled substances to DEA to comply with Federal law and international treaty obligations. This information helps to ensure the closed system of distribution for these substances.

US Code: 21 USC 827 Name of Law: Records and Reports of Registrants
  
None

Not associated with rulemaking

  76 FR 10391 02/24/2011
76 FR 24057 04/29/2011
No

1
IC Title Form No. Form Name
ARCOS Transaction Reporting -- DEA Form 333 333 ARCOS

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 6,856 7,768 0 0 -912 0
Annual Time Burden (Hours) 6,856 7,768 0 0 -912 0
Annual Cost Burden (Dollars) 218 9,077 0 0 -8,859 0
No
No

$150,000
No
No
No
No
No
Uncollected
Mark Caverly 202 307-7297

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
06/07/2011


© 2024 OMB.report | Privacy Policy